Literature DB >> 28410486

How to treat Ebola virus infections? A lesson from the field.

Sophie Duraffour1, Denis Malvy2, Daouda Sissoko3.   

Abstract

The reported case fatality ratios (CFR) of Ebola virus disease (EVD) have been as high as 90% in previous outbreaks. While the cumulative CFR among patients medically evacuated and treated in Western countries was inferior to 20%, it peaked to approximately 75% between September and December 2014 in West Africa, thereafter decreasing to less than 40% (May 2015) without current evidence of major virus mutations capable to alter virus pathogenicity over the course of the epidemic. Therefore, the observed diminution of CFR is likely to reflect improvement of EVD patient care. Here, we summarize major lessons learned, that is, progresses and knowledge gaps, about the clinical management of patients in West African settings during the 2014-2016 outbreak.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28410486     DOI: 10.1016/j.coviro.2017.03.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  5 in total

1.  Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials.

Authors:  Melba F Gomes; Vânia de la Fuente-Núñez; Abha Saxena; Annette C Kuesel
Journal:  Reprod Health       Date:  2017-12-14       Impact factor: 3.223

2.  Marburg virus re-emerged in 2022: recently detected in Ghana, another zoonotic pathogen coming up amid rising cases of Monkeypox and ongoing COVID-19 pandemic- global health concerns and counteracting measures.

Authors:  Ranjit Sah; Aroop Mohanty; Abdullah Reda; Abdelmonem Siddiq; Ranjan K Mohapatra; Kuldeep Dhama
Journal:  Vet Q       Date:  2022-12       Impact factor: 8.071

Review 3.  Marburg virus disease: A summary for clinicians.

Authors:  Mark G Kortepeter; Kerry Dierberg; Erica S Shenoy; Theodore J Cieslak
Journal:  Int J Infect Dis       Date:  2020-08-03       Impact factor: 3.623

Review 4.  Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.

Authors:  Kuldeep Dhama; Kumaragurubaran Karthik; Rekha Khandia; Sandip Chakraborty; Ashok Munjal; Shyma K Latheef; Deepak Kumar; Muthannan Andavar Ramakrishnan; Yashpal Singh Malik; Rajendra Singh; Satya Veer Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

Review 5.  [Epidemic and emerging prone-infectious diseases: Lessons learned and ways forward].

Authors:  Denis Malvy; Bernard-Alex Gaüzère; René Migliani
Journal:  Presse Med       Date:  2019-11-26       Impact factor: 1.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.